Time New York: Sun 22 Oct 18:46 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Why You Shouldn’t Bet Against Canadian Pacific Railway (CP) Stock

Zacks

One stock that might be an intriguing choice for investors right now is Canadian Pacific Railway Limited CP. This is because this security in the Transportation – Railspace is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Transportation – Rail space as it currently has a Zacks Industry Rank of 38 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Canadian Pacific Railway is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

Canadian Pacific Railway Limited Price and Consensus

Canadian Pacific Railway Limited Price and Consensus | Canadian Pacific Railway Limited Quote


In fact, over the past month, current quarter estimates have risen from $1.95 per share to $2.03 per share, while current year estimates have risen from $8.53 per share to $8.83 per share. This has helped CP to earn a Zacks Rank #2 (Buy), further underscoring the company’s solid position. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So, if you are looking for a decent pick in a strong industry, consider Canadian Pacific Railway. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

More Stock News: 8 Companies Verge on Apple-Like Run

Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.

A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.